Literature DB >> 29446321

Pulmonary IL-1β expression in early life causes permanent changes in lung structure and function in adulthood.

Anna Hogmalm1, Maija Bry2, Kristina Bry1,2.   

Abstract

Chorioamnionitis, mechanical ventilation, oxygen therapy, and postnatal infection promote inflammation in the newborn lung. The long-term consequences of pulmonary inflammation during infancy have not been well characterized. The aim of this study was to examine the impact of inflammation during the late saccular to alveolar stages of lung development on lung structure and function in adulthood. To induce IL-1β expression in the pulmonary epithelium of mice with a tetracycline-inducible human IL-1β transgene, doxycycline was administered via intraperitoneal injections to bitransgenic pups and their littermate controls on postnatal days (PN) 0, 0.5, and 1. Lung structure, inflammation, and airway reactivity were studied in adulthood. IL-1β production in early life resulted in increased numbers of macrophages and neutrophils on PN21, but inflammation subsided by PN42. Permanent changes in alveolar structure, i.e., larger alveoli and thicker alveolar walls, were present from PN21 to PN84. Lack of alveolar septation thus persisted after IL-1β production and inflammation had ceased. Early IL-1β production caused goblet cell hyperplasia, enhanced calcium-activated chloride channel 3 (CLCA3) protein expression, and increased airway reactivity in response to methacholine on PN42. Lymphoid follicles were present adjacent to small airways in the lungs of adult bitransgenic mice, and levels of the B cell chemoattractant CXC-motif ligand (CXCL) 13 were elevated in the lungs of bitransgenic mice compared with controls. In conclusion, IL-1β-induced pulmonary inflammation in early life causes a chronic lung disease in adulthood.

Entities:  

Keywords:  IL-1β; airway reactivity; alveolar morphogenesis; inflammation

Mesh:

Substances:

Year:  2018        PMID: 29446321     DOI: 10.1152/ajplung.00256.2017

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  6 in total

1.  Perinatal maternal antibiotic exposure augments lung injury in offspring in experimental bronchopulmonary dysplasia.

Authors:  Kent A Willis; David T Siefker; Michael M Aziz; Catrina T White; Naiha Mussarat; Charles K Gomes; Amandeep Bajwa; Joseph F Pierre; Stephania A Cormier; Ajay J Talati
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-10-23       Impact factor: 5.464

Review 2.  Postnatal Sepsis and Bronchopulmonary Dysplasia in Premature Infants: Mechanistic Insights into "New BPD".

Authors:  Umar Salimi; Krishna Dummula; Megan H Tucker; Charles S Dela Cruz; Venkatesh Sampath
Journal:  Am J Respir Cell Mol Biol       Date:  2022-02       Impact factor: 7.748

3.  IL-1β dysregulates cGMP signaling in the newborn lung.

Authors:  Ying Zhong; Kristina Bry; Jesse D Roberts
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-05-06       Impact factor: 5.464

4.  Transcriptional profiling of lung macrophages identifies a predictive signature for inflammatory lung disease in preterm infants.

Authors:  Debashis Sahoo; Livia S Zaramela; Gilberto E Hernandez; Uyen Mai; Sahar Taheri; Dharanidhar Dang; Ashley N Stouch; Rachel M Medal; Alyssa M McCoy; Judy L Aschner; Timothy S Blackwell; Karsten Zengler; Lawrence S Prince
Journal:  Commun Biol       Date:  2020-05-22

Review 5.  Pulmonary Consequences of Prenatal Inflammatory Exposures: Clinical Perspective and Review of Basic Immunological Mechanisms.

Authors:  Courtney M Jackson; Shibabrata Mukherjee; Adrienne N Wilburn; Chris Cates; Ian P Lewkowich; Hitesh Deshmukh; William J Zacharias; Claire A Chougnet
Journal:  Front Immunol       Date:  2020-06-19       Impact factor: 7.561

6.  Regulation of JAM2 Expression in the Lungs of Streptozotocin-Induced Diabetic Mice and Human Pluripotent Stem Cell-Derived Alveolar Organoids.

Authors:  Roya Rasaei; Eunbi Kim; Ji-Young Kim; Sunghun Na; Jung-Hyun Kim; Jinbeom Heo; Dong-Myung Shin; Sun Shim Choi; Seok-Ho Hong
Journal:  Biomedicines       Date:  2020-09-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.